PapersFlow Research Brief
Nanoparticle-Based Drug Delivery
Research Guide
What is Nanoparticle-Based Drug Delivery?
Nanoparticle-based drug delivery is the development and application of nanoparticles as carriers to transport therapeutic agents to specific sites in the body, particularly for cancer therapy, leveraging properties such as tumor targeting and the enhanced permeability and retention (EPR) effect.
This field encompasses 84,814 papers focused on nanocarriers, surface engineering of nanoparticles, magnetic nanoparticles, polymeric nanoparticles, and their biomedical applications. Research addresses synthesis, functionalization, and targeting mechanisms including the EPR effect. Key advancements include precision engineering and stimuli-responsive designs for improved drug efficacy.
Topic Hierarchy
Research Sub-Topics
Polymeric Nanoparticles for Drug Delivery
This sub-topic covers the synthesis, characterization, and optimization of polymeric nanoparticles such as PLGA and PEG-based systems for controlled drug release. Researchers study their biocompatibility, degradation profiles, and efficacy in encapsulating hydrophobic and hydrophilic therapeutics.
Magnetic Nanoparticles in Biomedicine
This sub-topic focuses on iron oxide nanoparticles for magnetic targeting, hyperthermia, and MRI contrast enhancement in drug delivery. Researchers investigate synthesis methods, surface coatings, and their interactions with biological systems under magnetic fields.
Stimuli-Responsive Nanocarriers
This sub-topic examines nanocarriers that respond to pH, temperature, light, or enzymes for triggered drug release at disease sites. Researchers develop and test smart materials to enhance specificity and minimize off-target effects.
Tumor Targeting Ligands on Nanoparticles
This sub-topic explores ligand functionalization of nanoparticles with antibodies, peptides, or aptamers for active tumor targeting beyond the EPR effect. Researchers evaluate binding affinity, internalization mechanisms, and in vivo targeting efficiency.
Nano-Bio Interface Interactions
This sub-topic investigates protein corona formation, cellular uptake pathways, and immune evasion of nanoparticles in biological media. Researchers model biophysicochemical interactions to predict in vivo performance and toxicity.
Why It Matters
Nanoparticle-based drug delivery enhances cancer therapy by enabling targeted delivery that minimizes off-target effects. Peer et al. (2007) in "Nanocarriers as an emerging platform for cancer therapy" highlight nanocarriers' role in overcoming biological barriers, with over 8,421 citations underscoring their impact. Mitchell et al. (2020) in "Engineering precision nanoparticles for drug delivery" detail designs achieving controlled release, applied in clinical trials for tumors. Magnetic nanoparticles, as reviewed by Lu et al. (2007) with 6,605 citations, facilitate vectorization and imaging in biomedical settings, while stimuli-responsive systems from Mura et al. (2013) improve payload delivery in acidic tumor environments.
Reading Guide
Where to Start
"Nanocarriers as an emerging platform for cancer therapy" by Peer et al. (2007), as it provides a foundational overview of nanocarriers, EPR effect, and cancer applications with broad applicability.
Key Papers Explained
Peer et al. (2007) "Nanocarriers as an emerging platform for cancer therapy" introduces core concepts, which Nel et al. (2009) "Understanding biophysicochemical interactions at the nano–bio interface" builds on by detailing nano-bio interactions. Mitchell et al. (2020) "Engineering precision nanoparticles for drug delivery" advances these with precision design strategies. Lu et al. (2007) "Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application" and Laurent et al. (2008) "Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications" complement by focusing on magnetic systems' synthesis and functionalization.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent emphasis is on engineering precision nanoparticles for clinical use, as in Mitchell et al. (2020), alongside stimuli-responsive nanocarriers from Mura et al. (2013). Focus persists on surface engineering for magnetic nanoparticles per Gupta and Gupta (2004) and overcoming barriers from Blanco et al. (2015). No recent preprints or news reported.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Scherrer Formula for X-Ray Particle Size Determination | 1939 | Physical Review | 8.6K | ✕ |
| 2 | Nanocarriers as an emerging platform for cancer therapy | 2007 | Nature Nanotechnology | 8.4K | ✕ |
| 3 | Understanding biophysicochemical interactions at the nano–bio ... | 2009 | Nature Materials | 6.8K | ✕ |
| 4 | Engineering precision nanoparticles for drug delivery | 2020 | Nature Reviews Drug Di... | 6.7K | ✓ |
| 5 | Synthesis and surface engineering of iron oxide nanoparticles ... | 2004 | Biomaterials | 6.6K | ✕ |
| 6 | Magnetic Nanoparticles: Synthesis, Protection, Functionalizati... | 2007 | Angewandte Chemie Inte... | 6.6K | ✕ |
| 7 | Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, V... | 2008 | Chemical Reviews | 6.6K | ✕ |
| 8 | Principles of nanoparticle design for overcoming biological ba... | 2015 | Nature Biotechnology | 6.4K | ✓ |
| 9 | Nano based drug delivery systems: recent developments and futu... | 2018 | Journal of Nanobiotech... | 6.2K | ✓ |
| 10 | Stimuli-responsive nanocarriers for drug delivery | 2013 | Nature Materials | 5.9K | ✕ |
Frequently Asked Questions
What are nanocarriers in nanoparticle-based drug delivery?
Nanocarriers are nanoparticle platforms designed for cancer therapy to encapsulate and deliver drugs selectively to tumors. Peer et al. (2007) in "Nanocarriers as an emerging platform for cancer therapy" describe their use in exploiting the EPR effect for passive targeting. These systems reduce systemic toxicity compared to free drugs.
How are magnetic nanoparticles synthesized for drug delivery?
Magnetic nanoparticles, primarily iron oxide, are synthesized via methods like co-precipitation followed by surface engineering for stability. Gupta and Gupta (2004) in "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications" outline functionalization for biocompatibility. Lu et al. (2007) in "Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application" detail protection strategies to prevent aggregation.
What is the role of the EPR effect in tumor targeting?
The EPR effect allows nanoparticles to accumulate in tumors due to leaky vasculature and poor lymphatic drainage. This passive targeting mechanism is central to polymeric and other nanocarriers. Blanco et al. (2015) in "Principles of nanoparticle design for overcoming biological barriers to drug delivery" explain design principles to maximize EPR utilization.
What are stimuli-responsive nanocarriers?
Stimuli-responsive nanocarriers release drugs in response to triggers like pH, temperature, or enzymes in tumor microenvironments. Mura et al. (2013) in "Stimuli-responsive nanocarriers for drug delivery" review mechanisms for site-specific payload discharge. These systems enhance therapeutic index by minimizing premature release.
How do nanoparticles overcome biological barriers?
Nanoparticles are engineered to evade immune clearance, cross endothelial barriers, and penetrate tissues via size, shape, and surface modifications. Nel et al. (2009) in "Understanding biophysicochemical interactions at the nano–bio interface" analyze protein corona formation and cellular uptake. Blanco et al. (2015) in "Principles of nanoparticle design for overcoming biological barriers to drug delivery" provide strategies for endosomal escape.
What is the current state of nanoparticle drug delivery systems?
The field includes over 84,814 works on diverse nanocarriers for cancer therapy. Mitchell et al. (2020) in "Engineering precision nanoparticles for drug delivery" emphasize precision designs for clinical translation. Patra et al. (2018) in "Nano based drug delivery systems: recent developments and future prospects" summarize advancements in polymeric and magnetic systems.
Open Research Questions
- ? How can nanoparticle surface properties be optimized to minimize protein corona formation and enhance tumor penetration?
- ? What synthesis methods yield magnetic nanoparticles with uniform size and high magnetic responsiveness for targeted delivery?
- ? Which stimuli-responsive mechanisms most effectively trigger drug release in heterogeneous tumor microenvironments?
- ? How do biophysicochemical interactions at the nano-bio interface influence long-term biodistribution and clearance?
- ? What design principles best overcome EPR heterogeneity across patient tumors for reliable passive targeting?
Recent Trends
The field maintains 84,814 papers with sustained focus on cancer therapy nanocarriers, precision engineering (Mitchell et al. 2020, 6,743 citations), and magnetic nanoparticle functionalization (Lu et al. 2007; Laurent et al. 2008).
Developments highlight stimuli-responsive systems (Mura et al. 2013) and nano-bio interface understanding (Nel et al. 2009).
No growth rate, recent preprints, or news available.
Research Nanoparticle-Based Drug Delivery with AI
PapersFlow provides specialized AI tools for Materials Science researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Engineering use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nanoparticle-Based Drug Delivery with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Materials Science researchers